NSC |
Compound |
Enrichment |
Correlation |
NSC 732737 |
Null |
0.0137891122538509 |
0.40352232 |
NSC 732825 |
N1-(4-methoxyphenyl)-4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihy dro-1H-3-pyrrolylamino)benzamide |
0.0137891122538509 |
0.47240669 |
NSC 751342 |
12H-Benzo[g]pyrido[2,1-b]quinazoline-4-carboxamide, N-[2(dimethylamino)ethyl]-12-oxo |
0.0137891122538509 |
0.15487843 |
NSC 756413 |
GW876790X |
0.0137891122538509 |
-0.23578808 |
NSC 89671 |
Ascotoxin |
0.0137891122538509 |
-0.056400992 |
NSC 129794 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.013789112253851 |
0.099334564 |
NSC 135687 |
5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) |
0.013789112253851 |
0.4214383 |
NSC 163424 |
4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- |
0.013789112253851 |
0.11996539 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.013789112253851 |
0.1873078 |
NSC 244404 |
Null |
0.013789112253851 |
0.19271786 |